The Family Firm’s RenovoRx RNXT Stock Holding History

The Family Firm’s Portfolio RNXT Stock Details RNXT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-1,000	Closed	-$1.13K	–	705
2024 Q2	$1.13K	Buy	+1,000	New	+$1.23K	﹤0.01%	827

Other funds holding RNXT

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

NPT

Nixon Peabody Trust Boston, Massachusetts $1.26B AUM 24.14% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

KAS

Kestra Advisory Services Austin, Texas $26.4B AUM 21.05% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ACA

Affinity Capital Advisors Berkeley, California $810M AUM 24.85% 1-Year Est. Return

The Family Firm's RNXT Position: Q3 2024 in Review

The Family Firm sold out of RenovoRx (RNXT) in Q3 2024, closing a stake of 1,000 shares — an estimated $1.13K sold.

The Family Firm first reported a position in RNXT in Q2 2024 and held it in 1 quarter. The position peaked at $1.13K in Q2 2024. 13 funds tracked by Wall St. Rank hold RNXT as of Q3 2024.

The Family Firm reported no remaining RenovoRx position as of Q3 2024 after selling out during the quarter.
The Family Firm sold 1,000 RenovoRx shares in Q3 2024, an estimated $1.13K.
The Family Firm first reported a position in RenovoRx in Q2 2024 and held it in 1 quarter.
The Family Firm's RenovoRx position peaked at $1.13K in Q2 2024.
13 funds tracked by Wall St. Rank held RenovoRx as of Q3 2024.

Based on The Family Firm's 13F filing for Q3 2024, filed 17 Oct 2024.